Literature DB >> 9636139

Defining the domains of type I collagen involved in heparin- binding and endothelial tube formation.

S M Sweeney1, C A Guy, G B Fields, J D San Antonio.   

Abstract

Cell surface heparan sulfate proteoglycan (HSPG) interactions with type I collagen may be a ubiquitous cell adhesion mechanism. However, the HSPG binding sites on type I collagen are unknown. Previously we mapped heparin binding to the vicinity of the type I collagen N terminus by electron microscopy. The present study has identified type I collagen sequences used for heparin binding and endothelial cell-collagen interactions. Using affinity coelectrophoresis, we found heparin to bind as follows: to type I collagen with high affinity (Kd approximately 150 nM); triple-helical peptides (THPs) including the basic N-terminal sequence alpha1(I)87-92, KGHRGF, with intermediate affinities (Kd approximately 2 microM); and THPs including other collagenous sequences, or single-stranded sequences, negligibly (Kd >> 10 microM). Thus, heparin-type I collagen binding likely relies on an N-terminal basic triple-helical domain represented once within each monomer, and at multiple sites within fibrils. We next defined the features of type I collagen necessary for angiogenesis in a system in which type I collagen and heparin rapidly induce endothelial tube formation in vitro. When peptides, denatured or monomeric type I collagen, or type V collagen was substituted for type I collagen, no tubes formed. However, when peptides and type I collagen were tested together, only the most heparin-avid THPs inhibited tube formation, likely by influencing cell interactions with collagen-heparin complexes. Thus, induction of endothelial tube morphogenesis by type I collagen may depend upon its triple-helical and fibrillar conformations and on the N-terminal heparin-binding site identified here.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9636139      PMCID: PMC22588          DOI: 10.1073/pnas.95.13.7275

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  46 in total

1.  Characteristics of the in vitro interaction of a small proteoglycan (PG II) of bovine tendon with type I collagen.

Authors:  D C Brown; K G Vogel
Journal:  Matrix       Date:  1989

2.  Type I collagen fibrils promote rapid vascular tube formation upon contact with the apical side of cultured endothelium.

Authors:  C J Jackson; K L Jenkins
Journal:  Exp Cell Res       Date:  1991-01       Impact factor: 3.905

3.  VLA-2 mediates the interaction of collagen with endothelium during in vitro vascular tube formation.

Authors:  C J Jackson; A Knop; I Giles; K Jenkins; L Schrieber
Journal:  Cell Biol Int       Date:  1994-09       Impact factor: 3.612

4.  Structure of a full-length cDNA clone for the prepro alpha 2(I) chain of human type I procollagen. Comparison with the chicken gene confirms unusual patterns of gene conservation.

Authors:  H Kuivaniemi; G Tromp; M L Chu; D J Prockop
Journal:  Biochem J       Date:  1988-06-15       Impact factor: 3.857

5.  Heparin type IV collagen interactions: equilibrium binding and inhibition of type IV collagen self-assembly.

Authors:  E C Tsilibary; G G Koliakos; A S Charonis; A M Vogel; L A Reger; L T Furcht
Journal:  J Biol Chem       Date:  1988-12-15       Impact factor: 5.157

6.  Edman degradation sequence analysis of resin-bound peptides synthesized by 9-fluorenylmethoxycarbonyl chemistry.

Authors:  C G Fields; V L VanDrisse; G B Fields
Journal:  Pept Res       Date:  1993 Jan-Feb

7.  Specific inhibition of type I and type II collagen fibrillogenesis by the small proteoglycan of tendon.

Authors:  K G Vogel; M Paulsson; D Heinegård
Journal:  Biochem J       Date:  1984-11-01       Impact factor: 3.857

8.  Specificity in the interactions of extracellular matrix proteins with subpopulations of the glycosaminoglycan heparin.

Authors:  J D San Antonio; J Slover; J Lawler; M J Karnovsky; A D Lander
Journal:  Biochemistry       Date:  1993-05-11       Impact factor: 3.162

9.  Fractionation of low molecular weight heparin species and their interaction with antithrombin.

Authors:  D Beeler; R Rosenberg; R Jordan
Journal:  J Biol Chem       Date:  1979-04-25       Impact factor: 5.157

10.  Inhibition of angiogenesis through modulation of collagen metabolism.

Authors:  D Ingber; J Folkman
Journal:  Lab Invest       Date:  1988-07       Impact factor: 5.662

View more
  32 in total

1.  Interaction of the collagen-like tail of asymmetric acetylcholinesterase with heparin depends on triple-helical conformation, sequence and stability.

Authors:  P Deprez; E Doss-Pepe; B Brodsky; N C Inestrosa
Journal:  Biochem J       Date:  2000-08-15       Impact factor: 3.857

2.  Inhibition of neovascularization and tumor growth, and facilitation of wound repair, by halofuginone, an inhibitor of collagen type I synthesis.

Authors:  R Abramovitch; H Dafni; M Neeman; A Nagler; M Pines
Journal:  Neoplasia       Date:  1999-10       Impact factor: 5.715

3.  Non-enzymatic glycation of type I collagen diminishes collagen-proteoglycan binding and weakens cell adhesion.

Authors:  Kristin L Reigle; Gloria Di Lullo; Kevin R Turner; Jerold A Last; Inna Chervoneva; David E Birk; James L Funderburgh; Elizabeth Elrod; Markus W Germann; Charles Surber; Ralph D Sanderson; James D San Antonio
Journal:  J Cell Biochem       Date:  2008-08-01       Impact factor: 4.429

Review 4.  Angiogenesis.

Authors:  Donald R Senger; George E Davis
Journal:  Cold Spring Harb Perspect Biol       Date:  2011-08-01       Impact factor: 10.005

5.  Effect of heparin on the biological properties and molecular signature of human mesenchymal stem cells.

Authors:  Ling Ling; Emily T Camilleri; Torben Helledie; Rebekah M Samsonraj; Drew M Titmarsh; Ren Jie Chua; Oliver Dreesen; Christian Dombrowski; David A Rider; Mario Galindo; Ian Lee; Wanjin Hong; James H Hui; Victor Nurcombe; Andre J van Wijnen; Simon M Cool
Journal:  Gene       Date:  2015-10-17       Impact factor: 3.688

Review 6.  Crafting of functional biomaterials by directed molecular self-assembly of triple helical peptide building blocks.

Authors:  Jayati Banerjee; Helena S Azevedo
Journal:  Interface Focus       Date:  2017-10-20       Impact factor: 3.906

7.  A polyelectrolyte multilayer platform for investigating growth factor delivery modes in human liver cultures.

Authors:  Christine Lin; Raimundo Romero; Lioudmila V Sorokina; Kimberly R Ballinger; Laura W Place; Matt J Kipper; Salman R Khetani
Journal:  J Biomed Mater Res A       Date:  2017-12-04       Impact factor: 4.396

Review 8.  Consortium for osteogenesis imperfecta mutations in the helical domain of type I collagen: regions rich in lethal mutations align with collagen binding sites for integrins and proteoglycans.

Authors:  Joan C Marini; Antonella Forlino; Wayne A Cabral; Aileen M Barnes; James D San Antonio; Sarah Milgrom; James C Hyland; Jarmo Körkkö; Darwin J Prockop; Anne De Paepe; Paul Coucke; Sofie Symoens; Francis H Glorieux; Peter J Roughley; Alan M Lund; Kaija Kuurila-Svahn; Heini Hartikka; Daniel H Cohn; Deborah Krakow; Monica Mottes; Ulrike Schwarze; Diana Chen; Kathleen Yang; Christine Kuslich; James Troendle; Raymond Dalgleish; Peter H Byers
Journal:  Hum Mutat       Date:  2007-03       Impact factor: 4.878

9.  Dual antiplatelet and anticoagulant (APAC) heparin proteoglycan mimetic with shear-dependent effects on platelet-collagen binding and thrombin generation.

Authors:  Jason Chen; Christopher C Verni; Annukka Jouppila; Riitta Lassila; Scott L Diamond
Journal:  Thromb Res       Date:  2018-07-25       Impact factor: 3.944

10.  In vitro evaluation of electrospun silk fibroin scaffolds for vascular cell growth.

Authors:  Xiaohui Zhang; Cassandra B Baughman; David L Kaplan
Journal:  Biomaterials       Date:  2008-02-14       Impact factor: 12.479

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.